Johnson & Johnson
Income Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Oct 2023 | Jul 2023 | Apr 2023 | Jan 2023 | Oct 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22.45B | $21.38B | $21.40B | $21.35B | $21.52B | $20.89B | $19.94B | $20.00B |
| Cost of Revenue | $6.87B | $6.51B | $6.80B | $6.61B | $6.46B | $6.69B | $2.91B | $6.17B |
| Gross Profit | $15.58B | $14.87B | $14.60B | $14.75B | $15.06B | $14.21B | $13.86B | $13.82B |
| Gross Margin | 69.4% | 69.6% | 68.2% | 69.1% | 70.0% | 68.0% | 69.5% | 69.1% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $5.68B | $5.26B | $5.81B | $5.40B | $5.40B | $4.91B | $3.11B | $4.98B |
| Operating Income | $5.75B | $3.87B | $4.85B | $5.41B | $6.65B | $-1.08B | $4.02B | $5.22B |
| Operating Margin | 25.6% | 18.1% | 22.7% | 25.3% | 30.9% | -5.1% | 20.1% | 26.1% |
| Interest Expense | — | $155.0M | $22.0M | $192.0M | $346.0M | $212.0M | $177.0M | $51.0M |
| Pretax Income | $5.75B | $3.71B | $4.83B | $5.22B | $6.31B | $-1.29B | $3.84B | $5.17B |
| Income Tax Expense | $1.06B | $459.0M | $694.0M | $908.0M | $930.0M | $-796.0M | $388.0M | $862.0M |
| Net Income | $4.69B | $3.26B | $4.05B | $26.03B | $5.14B | $-68.0M | $3.52B | $4.46B |
| Net Margin | 20.9% | 15.2% | 18.9% | 121.9% | 23.9% | -0.3% | 17.7% | 22.3% |
| EPS (Basic) | $1.95 | $1.35 | $1.68 | $10.32 | $1.98 | $-0.03 | $1.35 | $1.70 |
| EPS (Diluted) | $1.93 | $1.34 | $1.67 | $10.21 | $1.96 | $-0.03 | $1.33 | $1.68 |
| Shares Outstanding (Basic) | 2.41B | 2.41B | 2.53B | 2.52B | 2.60B | 2.61B | 2.63B | 2.63B |
| Shares Outstanding (Diluted) | 2.42B | 2.43B | 2.56B | 2.55B | 2.63B | 2.61B | 2.66B | 2.66B |
| Dividends Per Share | $1.24 | $1.19 | $1.19 | $1.19 | $1.19 | $1.13 | $1.13 | $1.13 |